09 Nov 2018 --- Biotechnology and fermentation innovator Evolva has responded to news of the DSM and Cargill sweetener joint venture announced yesterday. The Swiss-headquartered company has stressed that Evolva’s royalty rights on EverSweet and their existing agreement with Cargill will remain unchanged as a result of the upcoming joint venture. In a business update, the company says that it expects full-year 2018 product sales to grow at a high double-digit percentage rate. At the same time, their sales development pipeline continues to gain momentum, supporting further growth in 2019.
